Essential features that serve to distinguish malignant cells from their normal counterparts include their ability to proliferate independently of normal regulatory mechanisms, invade normal tissue and metastasize. Increasing evidence suggests that these characteristics may be modulated by the tumor cell's nucleus and surface membranes. Colorectal cancer is a leading cause of death among adult patients with internal malignancies and is incurable in approximately one-half of the patients at the time of initial diagnosis. In the past two decades, cure rates of the disease have stayed approximately the same. Elucidation of the surface membrane and intracellular events that occur during normal differentiation, those altered leading to an occurring during malignant transformation as well as better methods for the early detection of this disease are clearly needed and are the overall goals of this proposal. To achieve these goals, proliferative and non-proliferative colonic epithelial cells will first be isolated from the proximal and distal rat colon. Lumenal and contralumenal plasma membranes will then be isolated from these cells. Each of these membranes will be characterized during normal differentiation with respect to: 1) phospholipid/neutral lipid composition; 2) phospholipid/neutral lipid turnover and biosynthesis; 3) membrane lipid """"""""fluidity"""""""" and protein-lipid interactions; 4) amiloride-sensitive Na+/H+ exchange; and 5) glycosphingolipid composition and biosynthesis. After this is accomplished in the """"""""normal"""""""" rat colon, animals will be treated with either the procarcinogen 1,2 dimethylhydrazine (DMH) or the direct carcinogen N-methyl-N'-nitro-N-nitroguadinine (MNNG) for 5, 10 or 15 weeks, i.e., prior to the development of overt colonic tumors. Colonic antipodal plasma membranes will then be isolated from proximal and distal colonocytes and their biochemical parameters (see above) analyzed. Differences in these parameters between """"""""normal"""""""" and carcinogen-treated membranes may be useful in detecting early or """"""""premalignant"""""""" changes. These differences might also prove useful in increasing our understanding of the malignant transformation process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA036745-06
Application #
3482359
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1983-07-01
Project End
1989-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Michael Reese Hosp & Medical Center (Chicago)
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60616
Hasebe, Takumu; Matsukawa, Jun; Ringus, Daina et al. (2017) Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer. Phytother Res 31:90-99
Chen, Nai-Tzu; Souris, Jeffrey S; Cheng, Shih-Hsun et al. (2017) Lectin-functionalized mesoporous silica nanoparticles for endoscopic detection of premalignant colonic lesions. Nanomedicine 13:1941-1952
Ueno, Nobuhiro; Hasebe, Takumu; Kaneko, Atsushi et al. (2014) TU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-?B suppression. PLoS One 9:e97456
Dougherty, Urszula; Mustafi, Reba; Sadiq, Farhana et al. (2014) The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer. Clin Cancer Res 20:5848-5859
Mustafi, Reba; Dougherty, Urszula; Shah, Hardik et al. (2012) Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts. Carcinogenesis 33:1930-9
Chen, Peili; Kartha, Sreedharan; Bissonnette, Marc et al. (2012) AMP-18 facilitates assembly and stabilization of tight junctions to protect the colonic mucosal barrier. Inflamm Bowel Dis 18:1749-59
Wang, Hanlin L; Hart, John; Fan, Lifang et al. (2011) Upregulation of glycogen synthase kinase 3? in human colorectal adenocarcinomas correlates with accumulation of CTNNB1. Clin Colorectal Cancer 10:30-6
Zhu, Hongyan; Dougherty, Urszula; Robinson, Victoria et al. (2011) EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res 9:960-75
Dougherty, Urszula; Mustafi, Reba; Wang, Yunwei et al. (2011) American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR. BMC Complement Altern Med 11:111
Holgren, C; Dougherty, U; Edwin, F et al. (2010) Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas. Oncogene 29:5241-53

Showing the most recent 10 out of 108 publications